Rosen Law Firm Examines Legal Claims for Disc Medicine, Inc. Investors

Investigation of Potential Securities Claims Against Disc Medicine

The Rosen Law Firm, a prominent advocate for investor rights, is continuing its investigation into potential securities claims concerning Disc Medicine, Inc. (NASDAQ: IRON). This inquiry is in response to allegations that the company may have provided materially misleading information about its business operations to the public and its investors.

Background on the Case

On February 13, 2026, Disc Medicine received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company’s application for its drug candidate, bitopertin. The letter indicated that the FDA was unable to approve Disc’s New Drug Application (NDA) due to certain uncertainties that were identified, which require additional evidence to address. Following this news, there was a significant impact on the company's stock price, which plummeted by 22% the same day.

What This Means for Investors

For individuals who purchased securities of Disc Medicine, a potential class action lawsuit could provide a pathway to recovering losses incurred as a result of these disclosures. Importantly, investors may not have to pay any out-of-pocket costs as compensation can be arranged through a contingency fee basis. This generally means that the law firm only gets paid if the case is successful, ensuring that investors do not face financial barriers to seeking justice.

How to Participate

Investors interested in joining the class action are encouraged to visit Rosen Law Firm's website or contact Phillip Kim, an attorney at the firm. They can reach him toll-free at 866-767-3653 or via email at [email protected] This initiative aims to gather all affected investors and file a comprehensive claim that seeks recovery for losses due to the alleged misleading information.

Why Choose Rosen Law Firm?

Rosen Law Firm has built a reputable history in representing global investors, particularly in securities class actions. They emphasize the importance of choosing legal representation with proven success in litigating these types of claims. Unlike many firms that may not have as much experience or resources, Rosen Law Firm stands out for its track record, having achieved significant settlements in the past, including the largest ever securities class action settlement against a Chinese company.

Since 2013, the firm has ranked within the top tiers of law firms in terms of settlements recovered for investors. For example, Rosen Law Firm successfully secured over $438 million in 2019 alone. In 2020, founding partner Laurence Rosen was distinguished as a Titan of the Plaintiff's Bar by Law360, underscoring the firm's dedication to investor rights.

Follow for Updates

For ongoing updates regarding this investigation or other investor-related news, interested parties can follow the Rosen Law Firm on their social media channels: LinkedIn, Twitter, and Facebook. With dedicated legal professionals on hand, Rosen Law Firm continues to strive for justice for investors worldwide.

Attorney Advertising

Additionally, it’s essential to note that previous results do not guarantee similar outcomes in future cases. This statement serves to inform investors about their rights and available options regarding the ongoing investigation into Disc Medicine, Inc.